Синтез оксида азота и развитие атеросклероза

Медицинский центр Управления делами Президента Российской Федерации, Москва

[1] [2] [3] [4] [5] [6] [7]

В начало...

40. Stoltz J.F., Boisseau M., Muller S. et al. Hemorheology and vascular endothelial cells. J Mal Vasc 1999; 24(2): 99-109.

41. Vallance P., Leone A., Collier J., Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992; 339: 572-575.

42. Boger R.H., Bode-Boger S.M., Thiele W., Frolich J.C. Biochemical evidens for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation 1997; 95: 2068-2074.

43. Cooke J.P. Role of nitric oxide in progression and regression of atherosclerosis. West J Med 1996; 164: 419-424.

44. Ocmar B.S., Tschudi M.R., Godoy N.etal. Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. Circulation 1998; 97: 2494-2498.

45. Marks D.S., Vita J.A., Foils J.D. et al. Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxid. J Clin Invest 1995; 96: 2630-2638.

46. Von Der Leyen H.E., Gibbons G.H., Morishia R. et al. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci USA 1995; 92: 1137-1141.

47. Dyke C.K., Proctor D.N., Dietz N.M., Joyner M.J. Role of nitric oxide in exercise hyperaemia during prolonged rhythmic handgripping in humans. J Physiol Lond 1995; 488(Pt 1): 259-265.

48. Gilligan D.M., Panza J.A., Kilcoyne C.M. et al. Contribution of endothelium-derived nitric oxide to exercise-induced vasodilation. Circulation 1994; 90: 2853-2858.

49. Hambrecht R., Hilbrich L., Erbs S. et al. Correction of endothelial dysfunction in chronic heart failure: additional effects of exercise training and oral L-arginine supplementation. J Am Coll Cardiol 2000; 35(3): 706-713.

50. Li H., Forstermann U. Nitric oxide in the pathogenesis of vascular disease. J Pathol 2000; 190(3): 244-254.

51. Hodgson J.M., Nair R., Sheehan H.M. et al. Endothelial dysfunction in coronary arteries precedes ultrasonic or angiographic evidence of atherosclerosis in patients with risk factors. J Am Coll Cardiol 1992; 19(3): 323A.

52. Reddy K.G., Nair R.N., Sheehan H.M., Hodgson J.M. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J Am Coll Cardiol 1994; 23(4): 833-843.

53. Zeiher A.M., Schachlinger V., Hohnloser S.H. et al. Coronary atherosclerotic wall thickening and vascular reactivity in humans. Elevated high-density lipoprotein levels ameliorate abnormal vasoconstriction in early atherosclerosis. Circulation 1994; 89(6): 2525-2532.

54. Gerhard M., Roddy M.A., Creager S.J., Creager M.A. Aging progressively impairs endothelium-dependent vasodilatation in forearm resistance vessels of humans. Hypertension 1996; 27(4): 849-853.

55. Taddei S., Virdis A., Ghiadoni L. et al. Aging and endothelial function in normotensive subjects and patients with essential hypertension. Circulation 1995; 91: 1981-1987.

56. Uehata A., Lieberman E.H., Meredith I. et al. Non-invasive assessment of flow-mediated vasodilatation in brachial arteries: diminished response in young males compared to females. Circulation 1992; 86 (Suppl 1): I-620.

57. Hashimoto M., Akishita M., Eto M.etal. Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle. Circulation 1995; 92(12): 3431-3435.

58. Brown N.J., Gainer J.V., Stein C.M., Vaughan D.E. Bradykinin stimulates tissue plasminogen activator release in human vasculature. Hypertension 1999; 33: 1431-1435.

59. Clarkson P., Celermajer D.S., Donald A.E. et al. Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels. J Am Coll Cardiol 1996; 28: 573-579.

60. Watts G.H., O'Brien S.F., Silvester W., Millar J.A. Impaired endothelium-dependent and independent dilatation of forearm resistance arteries in men with diet-treated noninsulin-dependent diabetes: role of dyslipidaemia. Clin Sci Colch 1996; 91(5): 567- 573.

61. Kiowski W., Linder L., Stoschitzky K. et al. Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 in clinically healthy smokers. Circulation 1994: 90(1): 27- 34.

62. McVeigh G.E., Lemay L., Morgan D., Cohn J.N. Effects of long-term cigarette smoking on endothelium-dependent responses in humane. Am J Cardiol 1996; 78(6): 668-672.

63. Vogel R.A. Coronary risk factors, endothelial function, and atherosclerosis: a review. Clin Cardiol 1997; 20: 426-432.

64. Keith M. Channon, HuSheng Qian, Neplioueva V. et al. In vivo gene transfer of nitric oxide synthase enhances vasomotor function in carotid arteries from normal and cholesterol-fed rabbits. Circulation 1998; 98: 1905-1911.

65. Chester A.H., O'Neil G.S., Moncada S. et al. Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteгies. Lancet 1990; 336: 897-900.

66. Ocmar В.S., Tschudi M.R., Godoy N.etal. Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. Circulation 1998; 97: 2494-2498.

67. Tsutsui M., Milstien S., Katusic Z.S. Effect of tetrahydrobiopterin on endothelial function in canine middle cerebral arteries. Circulat Res 1996; 79: 336-342.

68. Harrison D.G. Cellular and molecular mechanism of endothelial cell dysfunction. J Clin Invest 1997; 100: 2153-2157.

69. Noll G. Pathogenesis of atherosclerosis: a possible relation to infection. Atherosclerosis 1998; 140 (Suppl 1): S3-S9.

70. Giuseppina Luvara, Maria E. Pueyo, Monique Philippe et al. Chronic blockade of NO synthase activity induces a proinflammatory phenotype in the arterial wall prevention by angiotensin II antagonism. Arterioscler Thromb Vasc Biol 1998; 18: 1408-1416.

71. Cooke J.P., Singer A.H., Tsao P. et al. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest 1992; 90: 1168-1172.

72. Cayatte A.J., Palacino J.J., Horten K. et al. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler Thromb 1994; 14: 753-759.

73. Kullo I.J., Mozes G., Schwartz R.S. et al. Adventitial gene transfer of recombinant endothelial nitric oxide synthase to rabbit carotid arteries alters vascular reactivity. Circulation 1997; 11369: 27507- 28110.

74. Radomski M.W., Palmer R.M.J., Moncada S. The role of nitric oxide and cGMF in platelet adhesion to vascular endothelium. Biochem Biophys Res Commun 1987; 148: 1482-1489.

75. Zeiher A.M., Fisslthaler В., Schray-Utz В. Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. Circulat Res 1995; 76: 980-986.

76. De Caterina R., Libby P., Peng H.-B. et al. Nitric oxide decreases cytokine induced endothelial activation: nitric oxide selectively reduces endothelial expression of adhesion molecules and proin-flammatory cytokines. J Clin Invest 1995; 96: 60-68.

77. HuSheng Qian, Neplioueva V., Geetha A. et al. Nitric oxide synthase gene therapy rapidly reduces adhesion molecule expression and inflammatory cell infiltration in carotid arteries of cholesterol-fed rabbits. Circulation 1999; 99: 2979-2982.

78. Ohara Y., Peterson Т.Е., Harrison D.G. Hypercholesterolemia increases endothelial superoxide anion production. Clin Invest 1993; 91: 2546-2551.

79. Todd J. Anderson. Assessment and treatment of endothelial dysfunction in humans. J Am Coll Cardiol 1999; 34(3); 631-638.

80. Guzik T.J., West N.E.J., Black E. et al. Vascular superoxide production by NAD(P)H oxidase. Circulat Res 2000: 86: E85-E90.

81. Buttery L.D.K., Springall D.R., Chester A.H. et al. Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest 1996; 75: 77-85.

82. Fielding C.J., Bist A., Fielding P.E. Caveolin mRNA levels are up-regulated by free cholesterol and down-regulated by oxysterols in fibroblast monolayers. Proc Natl Acad Sci USA 1997; 94: 3753-3758.

83. Bist A., Fielding C.J., Fielding P.E. Two sterol regulatory element-like sequences mediate up-regulation of caveolin gene transcription in responce to low density lipoprotein free cholesterol. Proc Natl Acad Sci USA 1997; 94: 10693-10698.

84. Bode-Boger S.M., Boger R.H., Frolich J.C. Elevated L-arginine/ dimethylarginine ratio contributes to enhanced systemic NO prodaction by dietary L-arginine in hypercholesterolemic rabbits. Biochem Biophys Res Commun 1996; 219: 598-603.

85. Marnett L.J., Wright T.L., Crews B.C. et al. Regulation of prostaglandin biosynthesis by nitric oxide is revealed by targeted deletion of inducible nitric oxide synthase. J Biol Chem 2000; 275: 13427- 13430.

86. Keith M. Channon, HuSheng Qian, George S.E. Nitric oxide synthase in atherosclerosis and vascular injury. Thromb Vasc Biol 2000; 20: 1873-1881.

87. Noll G., Luscher T.F. Influence of lipoproteins of endothelial function. Thromb Res 1994; 74: S45-S54.

88. Sawamura Т., Kume N., Aoyami T. et al. An endothelial receptor for oxidized low-density lipoprotein. Nature 1997; 386: 73.

89. Wever R., Stoes E., Rabelink T.J. Nitric oxide and hypercholesterolemia: a matter of oxidation and reduction? Atherosclerosis 1998; 137 (Suppl): 51S-60S.

Далее...